Page 5 - தலை ஆஃப் பெருநிறுவன தகவல்தொடர்புகள் முதலீட்டாளர் உறவுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Basilea Pharmaceutica AG: Basilea shareholders approve all proposals of the board of directors at the annual general meeting
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Sartorius with first-quarter uptick in sales and earnings
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
First-quarter results of Sartorius Stedim Biotech
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
First-quarter results of Sartorius Stedim Biotech
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Basilea announces closing of previously announced transaction regarding divestment of its .
Basilea Pharmaceutica AGApril 1, 2021 GMT
Basel, Switzerland, April 01, 2021
Basilea Pharmaceutica Ltd. (SIX: BSLN) today announced the successful closing of the previously announced divestment of its Chinese research and development (R&D) subsidiary Basilea Pharmaceutica China Ltd. (“BPC”) to the U.S.-based custom manufacturing organization PHT International Inc. (“PHT”) for a total consideration of USD 6.3 million. Basilea has received the initial payment of USD 2.5 million and is entitled to receive additional payments of USD 3.8 million over the course of the next three years. All 72 employees of BPC and the facilities have been transferred to PHT. PHT continues to provide R&D services to Basilea through the existing site in China.